Thomas M. is an ophthalmology project leader at Roche, where they currently research precise CRISPR/Cas9-based genome editing strategies for regenerative medicine. Thomas held roles as a postdoctoral scientist and senior scientist at Roche from 2020 to 2023. They have also served as a PhD candidate and postdoctoral researcher at the Center for iPS Cell Research and Application (CiRA) between 2017 and 2020. Thomas began their academic journey at EPFL, earning a master’s degree in 2015, and later obtained a doctorate from Kyoto University in 2020, following graduate research positions at esteemed institutions, including MIT and the University of Tokyo.
This person is not in the org chart
This person is not in any teams
This person is not in any offices